AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

GlobeImmune, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.04
Market Cap
575
AVG Volume
532
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Revenue (USD) by quarter
PeriodRevenue (USD)
16 Q1942.75K
15 Q41.05M
15 Q32.94M
15 Q21.28M
15 Q11.19M
14 Q41.51M
14 Q31.31M
14 Q21.73M
14 Q11.42M
13 Q413.83M
Net Income (USD)
-10M-5M05M10M15M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Net Income (USD) by quarter
PeriodNet Income (USD)
16 Q1-862.21K
15 Q4-795.03K
15 Q3893.6K
15 Q2-1.3M
15 Q1-1.56M
14 Q4-1.74M
14 Q3-6.36M
14 Q2-5.71M
14 Q1-2.44M
13 Q410.65M
Operating Income (USD)
-5M05M10M15M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Operating Income (USD) by quarter
PeriodOperating Income (USD)
16 Q1-862.21K
15 Q4-795.03K
15 Q3893.6K
15 Q2-1.3M
15 Q1-1.56M
14 Q4-1.74M
14 Q3-1.54M
14 Q2-1.34M
14 Q1-1.2M
13 Q410.38M
EBITDA (USD)
-10M-5M05M10M15M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM EBITDA (USD) by quarter
PeriodEBITDA (USD)
16 Q1-843.12K
15 Q4-775.48K
15 Q3914.13K
15 Q2-1.24M
15 Q1-1.48M
14 Q4-1.66M
14 Q3-6.11M
14 Q2-3.42M
14 Q1-888.02K
13 Q410.5M
Cash Flows (USD)
-4M-3M-2M-1M01M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Cash Flows (USD) by quarter
PeriodCash Flows (USD)
16 Q1-1.21M
15 Q4-1.41M
15 Q3-1.31M
15 Q2-1.99M
15 Q1-2.46M
14 Q4-2.09M
14 Q3-2.19M
14 Q2-2.78M
14 Q1-3.29M
13 Q484.23K
EPS (USD)
-2002040608013 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM EPS (USD) by quarter
PeriodEPS (USD)
16 Q1-0.15
15 Q4-0.14
15 Q30.13
15 Q2-0.23
15 Q1-0.27
14 Q4-0.3
14 Q3-1.13
14 Q2-1.04
14 Q1-0.44
13 Q475.79
Expenses (USD)
01M2M3M4MR&DSG&ACapex13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Expenses (USD) by quarter
PeriodExpenses (USD)
16 Q11.79M
15 Q41.82M
15 Q32.03M
15 Q22.52M
15 Q12.69M
14 Q43.22M
14 Q32.84M
14 Q23.16M
14 Q12.56M
13 Q43.34M
Cash & Debt (USD)
05M10M15M20MCashLong Term DebtShort Term Debt13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
16 Q18.69M
15 Q49.9M
15 Q311.3M
15 Q212.37M
15 Q114.36M
14 Q416.81M
14 Q318.89M
14 Q26.46M
14 Q19.22M
13 Q45.92M
Debt ratios
-300-200-100010013 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Debt ratios by quarter
PeriodDebt ratios
16 Q14.48
15 Q43.84
15 Q33.26
15 Q21.18
15 Q11.13
14 Q41.39
14 Q3-220.91
14 Q2-0.35
14 Q1-0.62
13 Q4-0.51
Margins
0%25%50%75%100%13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Margins by quarter
PeriodMargins
16 Q145.4%
15 Q477.78%
15 Q380.31%
15 Q241.07%
15 Q18.84%
14 Q419.56%
14 Q30.01%
14 Q213.16%
14 Q131.77%
13 Q488.65%
Return on Capital
-100%-50%0%50%13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Return on Capital by quarter
PeriodReturn on Capital
16 Q1-40.1%
15 Q4-26.6%
15 Q323.8%
15 Q2-46.02%
15 Q1-38.1%
14 Q4-31.08%
14 Q3-86.87%
14 Q22.67%
14 Q11.19%
13 Q4-5.34%
Shares Outstanding
02M4M6M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Shares Outstanding by quarter
PeriodShares Outstanding
16 Q15.75M
15 Q45.75M
15 Q35.75M
15 Q25.75M
15 Q15.75M
14 Q45.75M
14 Q35.63M
14 Q25.52M
14 Q15.52M
13 Q498.07K
Book Value Per Share (USD)
-3000-2000-10000100013 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
16 Q10.37
15 Q40.52
15 Q30.65
15 Q20.49
15 Q10.71
14 Q40.97
14 Q31.3
14 Q2-38.83
14 Q1-37.18
13 Q4-2032.51
Total Assets (USD)
010M20M30M13 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q416 Q1
GBIM Total Assets (USD) by quarter
PeriodTotal Assets (USD)
16 Q19.77M
15 Q411.51M
15 Q313.21M
15 Q213.54M
15 Q115.44M
14 Q418.37M
14 Q320.66M
14 Q210.21M
14 Q112.09M
13 Q47.42M
Employee Count
010203020142015
GBIM Employee Count by quarter
PeriodEmployee Count
20152
201422
PE Ratio
0102030med 12.64Jul 14Aug 14Sep 14Oct 14Oct 14Nov 14Dec 14
GBIM PE Ratio by quarter
PeriodPE Ratio
Dec 1422.14
Dec 1420.58
Dec 1422.83
Dec 1420.67
Nov 1420.21
Nov 1421.52
Nov 1419.44
Nov 1419.62
Oct 1417.37
Oct 1415.76
Oct 1418.88
Oct 1426.25
Oct 1429.8
Sep 145.29
Sep 145.61
Sep 146.76
Sep 146.41
Aug 146.83
Aug 146.05
Aug 145.41
Aug 146.46
Aug 145.4
Jul 146.83
Jul 147.95
Jul 149.51
Jul 147.62
Free Cash Flow Yield
-150000000%-100000000%-50000000%0%med -1028709.56%Jan 25May 25Sep 25Jan 26May 26Sep 26
GBIM Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1028709.53%
Sep 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Aug 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jul 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
Jun 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
May 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Apr 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Mar 26-1028709.56%
Feb 26-1028709.56%
Feb 26-1028709.56%
Feb 26-102870953.24%
Feb 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.56%
Jan 26-1028709.53%
Dec 25-1028709.56%
Dec 25-1028709.56%
Dec 25-1028709.56%
Dec 25-1028709.56%
Nov 25-1028709.53%
Nov 25-1028709.56%
Nov 25-1028709.53%
Nov 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Oct 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.56%
Sep 25-1028709.53%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Aug 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jul 25-1028709.56%
Jun 25-1028709.56%
Jun 25-514354.78%
Jun 25-514354.78%
Jun 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
May 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Apr 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Mar 25-514354.78%
Feb 25-514354.77%
Feb 25-514354.78%
Feb 25-514354.78%
Feb 25-514354.78%
Jan 25-514354.78%
Jan 25-514354.78%
Jan 25-514354.78%
Jan 25-102870953.24%
Jan 25-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Dec 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Nov 24-514354.78%
Oct 24-514354.78%
Oct 24-514354.78%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GBIM Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
EV/EBITDA
0100200300med 6.14Jul 14Aug 14Oct 14Nov 14Jan 15Feb 15Mar 15
GBIM EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 15265.89
Mar 15267.2
Mar 15244.84
Mar 15246.81
Feb 15276.41
Feb 15279.7
Feb 15295.49
Feb 15224.44
Jan 15217.21
Jan 15222.47
Jan 15207.34
Jan 15294.17
Jan 15281.68
Dec 146.6
Dec 146.11
Dec 146.82
Dec 146.14
Nov 145.99
Nov 146.4
Nov 145.75
Nov 145.81
Oct 145.1
Oct 144.6
Oct 145.58
Oct 147.89
Oct 149
Sep 143.73
Sep 144
Sep 144.95
Sep 144.66
Aug 145.01
Aug 144.37
Aug 143.83
Aug 144.7
Aug 143.83
Jul 145.01
Jul 145.93
Jul 147.22
Jul 145.66
Price/Operating Cashflow
2025303540med 25.3Jul 14Jul 14Aug 14Aug 14Aug 14Sep 14Sep 14
GBIM Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 1420.71
Sep 1422
Sep 1426.48
Sep 1425.12
Aug 1426.76
Aug 1423.72
Aug 1421.19
Aug 1425.3
Aug 1421.17
Jul 1426.79
Jul 1431.15
Jul 1437.27
Jul 1429.86
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GBIM Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
GlobeImmune, Inc.
GBIM
Stockpicker

Video analysis: GBIM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.